Cogstate Limited
COGZF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$593.84M
Close$
$1.48
37.8% downside
Current Fair Value
37.8% downsideOvervalued by 37.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $593.84 Million |
|---|---|
| Enterprise Value | $564.76 Million |
| Annual dividend | $0.04 |
| Dividend yield | 1.74% |
| Earnings per Share | $0.07 |
| Beta | 0.19 |
| Outstanding Shares | 170,728,180 |
Return
| Return on Equity | 38.14% |
|---|---|
| Return on Assets | 28.47% |
| Return on Invested Capital | 42.58% |
Valuation & Multiples
| P/E Ratio | 34.92 |
|---|---|
| PEG | 273.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.02 |
| Enterprise Value to EBIT | 21.64 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$0.04
Consensus analyst estimateRevenue Estimate
$33.40 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$34.20 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cogstate Limited
160 employees
CEO: Bradley John O'Connor
Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations. Its comprehensive suite of ...